Safety Study of S-CKD602 in Patients With Advanced Malignancies
NCT00177281
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
S CKD602
Sponsor
University of Pittsburgh
Collaborators
[object Object]